Nanyang Xiaoyang Network Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Nanyang Xiaoyang Network Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LNMMOOK. The owner is based in Nanyang City, Henan.

Zhongjing Street, Wancheng District

Nanyang City, Henan 473000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LNMMOOK
LNMMOOK
Registered 2023

Trademark Classifications

Nanyang Xiaoyang Network Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Nanyang Xiaoyang Network Technology Co., Ltd. have?

Nanyang Xiaoyang Network Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Nanyang Xiaoyang Network Technology Co., Ltd. file in?

Nanyang Xiaoyang Network Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Nanyang Xiaoyang Network Technology Co., Ltd.'s most well-known trademarks?

Nanyang Xiaoyang Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as LNMMOOK. These are among 1 currently registered trademark in the portfolio.

What is Nanyang Xiaoyang Network Technology Co., Ltd.'s trademark registration success rate?

Nanyang Xiaoyang Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.